SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-053563
Filing Date
2020-11-12
Accepted
2020-11-12 16:11:31
Documents
62
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ktra-10q_20200930.htm 10-Q 1999078
2 EX-10.1 ktra-ex101_319.htm EX-10.1 19085
3 EX-31.1 ktra-ex311_11.htm EX-31.1 21223
4 EX-31.2 ktra-ex312_10.htm EX-31.2 21280
5 EX-32.1 ktra-ex321_9.htm EX-32.1 8823
6 EX-32.2 ktra-ex322_8.htm EX-32.2 8895
7 GRAPHIC ge3t3fy0fcvy000002.jpg GRAPHIC 13788
8 GRAPHIC ge3t3fy0fcvy000003.jpg GRAPHIC 15994
9 GRAPHIC ge3t3fy0fcvy000001.jpg GRAPHIC 28654
  Complete submission text file 0001564590-20-053563.txt   7262855

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT ktra-20200930.xml EX-101.INS 1449089
11 XBRL TAXONOMY EXTENSION SCHEMA ktra-20200930.xsd EX-101.SCH 65486
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ktra-20200930_cal.xml EX-101.CAL 28275
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ktra-20200930_def.xml EX-101.DEF 250322
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE ktra-20200930_lab.xml EX-101.LAB 442558
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ktra-20200930_pre.xml EX-101.PRE 368134
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
Kintara Therapeutics, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-37823 | Film No.: 201306779
SIC: 2834 Pharmaceutical Preparations